What Is Dihexa?
Dihexa research has emerged as one of the most compelling areas in cognitive neuroscience, with this synthetic oligopeptide demonstrating potent activity at the hepatocyte growth factor (HGF) and MET receptor system — a signaling axis critically involved in neurogenesis, synaptic plasticity, and hippocampal function — in preclinical models.
Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, molecular weight approximately 592 Da) is a synthetic oligopeptide derived from angiotensin IV, developed at Washington State University by Joseph Harding and colleagues. It was designed as a blood-brain-barrier-penetrant activator of the HGF/MET signaling pathway — a receptor tyrosine kinase system that plays critical roles in neuronal survival, synaptogenesis, and adult hippocampal neurogenesis. Dihexa does not act as a direct MET receptor agonist but rather potentiates endogenous HGF binding at the MET receptor, amplifying downstream signaling at concentrations far below those achievable with exogenous HGF. This mechanism of potentiation rather than direct agonism is mechanistically novel and distinguishes Dihexa from other neurotrophic research compounds.
Preclinical studies have demonstrated Dihexa’s capacity to enhance cognitive performance in models of neurodegeneration and normal aging, with researchers noting its ability to produce robust effects at remarkably low nanomolar concentrations — reportedly several orders of magnitude more potent than other neurotrophic compounds including BDNF in some experimental paradigms.
Mechanism of Action
HGF/MET Pathway Potentiation
The central mechanism of Dihexa involves potentiation of hepatocyte growth factor (HGF) signaling at the MET receptor. HGF/MET signaling in the CNS drives multiple processes critical to neuronal health and plasticity: dendritic arborization, axonal growth, synaptic vesicle clustering, and the promotion of long-term potentiation (LTP). Dihexa binds to a site on HGF that facilitates MET receptor dimerization and activation — essentially acting as a molecular chaperone that enhances the efficiency of endogenous HGF-MET interactions rather than replacing them.
Synaptogenesis and Dendritic Spine Formation
Research has demonstrated that Dihexa promotes synaptogenesis in hippocampal neurons — increasing both the density and maturity of dendritic spines, the structural sites of excitatory synaptic contact. Mature dendritic spine morphology is closely associated with synaptic strength and long-term memory encoding. The promotion of dendritic spine formation through HGF/MET signaling represents a structural mechanism for cognitive enhancement that complements functional neurotransmitter-based approaches.
Neurogenesis Promotion
HGF/MET signaling is an established driver of adult hippocampal neurogenesis — the process by which new neurons are generated in the dentate gyrus of the hippocampus throughout life. Hippocampal neurogenesis is strongly associated with learning, memory consolidation, and resilience to depression and anxiety. Research has examined Dihexa’s ability to promote neurogenesis in models of age-related hippocampal decline and neurodegeneration.
BDNF Pathway Interaction
HGF/MET and BDNF/TrkB signaling pathways converge on many of the same downstream effectors — including PI3K/Akt, MAPK/ERK, and PLC-γ — and interact cooperatively in promoting synaptic plasticity. Research has investigated the relationship between Dihexa-driven HGF/MET activation and BDNF pathway function, and whether co-engagement of both pathways produces additive neuroplasticity outcomes.
Research Applications
Age-Related Cognitive Decline Research
The most extensively studied application for Dihexa concerns age-related cognitive decline. Hippocampal HGF/MET signaling declines with age — concurrent with age-related reductions in dendritic spine density, hippocampal neurogenesis, and cognitive performance. Research has examined Dihexa’s ability to restore cognitive performance metrics in aged animal models where HGF/MET signaling has declined, investigating whether HGF pathway potentiation can reverse structural and functional markers of hippocampal aging.
Neurodegenerative Disease Models
HGF/MET signaling dysregulation has been implicated in multiple neurodegenerative conditions, including Alzheimer’s disease, Parkinson’s disease, and ALS. Research has examined Dihexa in relevant animal models, investigating its effects on neuronal survival, synaptic density, and behavioral outcomes relevant to these conditions. The compound’s ability to penetrate the blood-brain barrier and engage a neuroprotective signaling pathway at low concentrations makes it a research tool of interest for neurodegeneration models where achieving adequate CNS exposure is a practical challenge.
Traumatic Brain Injury Research
HGF/MET signaling is upregulated in the brain following traumatic injury as part of an endogenous neuroprotective response. Research has investigated whether exogenous HGF pathway potentiation through Dihexa can amplify this protective response, reduce secondary neuronal loss, and improve functional recovery outcomes in TBI models.
Synaptogenesis and Learning Research
The fundamental role of synaptogenesis in learning and memory formation makes Dihexa a tool for basic neuroscience research on the structural plasticity mechanisms underlying cognitive function. Research has examined its effects on LTP induction, synaptic vesicle dynamics, and learning behavior across multiple paradigms — providing mechanistic data on how HGF/MET-driven synaptogenesis contributes to cognitive performance.
Dihexa in the AminoForge Cognitive Research Catalog
Researchers investigating cognitive biology and neuroprotection may find Dihexa most productive when studied alongside compounds targeting complementary neurological mechanisms. At AminoForge, the cognitive research catalog includes Semax — a melanocortin receptor peptide with BDNF-upregulating and neuroprotective properties — and Selank, studied for anxiolytic and nootropic mechanisms through GABAergic and BDNF pathways. For researchers investigating the neuropeptide bioregulator class, Pinealon offers complementary tissue-specific neuroprotective mechanisms. For further reading on HGF/MET signaling in cognitive research, see Dihexa and HGF/MET potentiation in cognitive models (PubMed).
Shop Dihexa at AminoForge — ≥99% purity, third-party COA verified, USA manufactured, ships within 48 hours.
Formulation and Storage
Dihexa is available as a lyophilized powder. With a molecular weight of approximately 592 Da, it is a small, relatively stable oligopeptide. Standard storage at −20°C for lyophilized powder applies, with reconstituted solutions stored at 2–8°C and protected from light. Bacteriostatic water is the standard reconstitution vehicle. Research-grade purity should be verified at ≥99% by HPLC with mass spectrometry confirmation of the correct molecular weight.
All products sold by AminoForge are intended exclusively for laboratory and research purposes. Not for human or veterinary consumption. Researchers are responsible for compliance with all applicable laws and regulations governing research compound use in their jurisdiction.